Integrating Practice with Precision: A Quantitative HER2 Protein Assay Developed for Clinical Application in Trastuzumab Deruxtecan Treatment Guidance - Top-Institutions - MDSpire

Integrating Practice with Precision: A Quantitative HER2 Protein Assay Developed for Clinical Application in Trastuzumab Deruxtecan Treatment Guidance

  • By

  • Junmei Hao

  • Xiaochun Fei

  • Fangfang Zou

  • Qian Hu

  • Linlin Du

  • Liya Yu

  • Xuanye Bai

  • Shasha Bi

  • Qinghua Cao

  • Weishan Chen

  • Qun Dai

  • Tingting Guo

  • Hai Huang

  • Wenwei Jiang

  • Baohua Li

  • Lixia Li

  • Jingjing Liu

  • Tong Liu

  • Xiaoqin Liu

  • Jiahong Lyu

  • Yue Pan

  • Xiaoqing Shao

  • Fangrong Tang

  • Tingting Wang

  • Cuiping Zhang

  • Yongcun Zhu

  • Job Tien Chiang Liu

  • Nicole Salazar

  • Shukun Zhang

  • Jiandi Zhang

  • Xiaosong Chen

  • Chaofu Wang

  • April 27, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Medical Oncology
    • Pathology
    • Breast Cancer Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Medical Oncology
    • Pathology
    • Translational Cancer Research

  • #3

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Medical Oncology
    • Pathology
    • Breast Cancer Clinical Research

  • #4

    Johns Hopkins Medicine
    Johns Hopkins Medicine

    Baltimore, MD

    Key Differentiators

    • Pathology
    • Oncology
    • Molecular Diagnostics

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Medical Oncology
    • Pathology
    • Breast Cancer Research

Original Source(s)

Integrating Practice with Precision: A Quantitative HER2 Protein Assay Developed for Clinical Application in Trastuzumab Deruxtecan Treatment Guidance

  • by Junmei Hao, Xiaochun Fei, Fangfang Zou, Qian Hu, Linlin Du, Liya Yu, Xuanye Bai, Shasha Bi, Qinghua Cao, Weishan Chen, Qun Dai, Tingting Guo, Hai Huang, Wenwei Jiang, Baohua Li, Lixia Li, Jingjing Liu, Tong Liu, Xiaoqin Liu, Jiahong Lyu, Yue Pan, Xiaoqing Shao, Fangrong Tang, Tingting Wang, Cuiping Zhang, Yongcun Zhu, Job Tien Chiang Liu, Nicole Salazar, Shukun Zhang, Jiandi Zhang, Xiaosong Chen, Chaofu Wang

  • April 27, 2026

Related Content

Vitamin D-related genetic variants as predictive biomarkers for breast cancer in Jordanian women

New Mammography Screening Guidance: Clinical Considerations for Risk-Based Care

New guidance from the American College of Physicians (ACP) recommends biennial mammography screening for average-risk women ages 50 to 74.

  • May 26, 2026

  • 5 min
Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy